Help Shape the Future of Arthritis
Join the ArthritisPower patient-centered research registry today.

ArthritisPower is a patient-led, patient-centered research registry for joint, bone, and inflammatory skin conditions. Our goal is to conduct research studies around questions and issues that matter most to patients. 

Track Your Symptoms
Complete health assessments in the ArthritisPower mobile app. Do this weekly or monthly to see changes in your condition.
Join Research Studies
We'll email you research studies that you may be eligible to participate in. They're all voluntary.
Contribute to Research
By participating in research studies and completing health assessments, you're helping our researchers develop better treatments.

Copyright © 2019 CreakyJoints

How Does It Work?


1. What conditions are included in the registry? 
2. Will ArthritisPower keep my information confidential?
Help Shape The Future of Arthritis
Join the ArthritisPower patient-centered research registry today.
We regularly collaborate with leading research institutions like Duke and Yale University to conduct arthritis-related research.  Our research studies are typically online surveys that ask you about certain aspects of living with arthritis.
Join Research Studies
When we have a study that matches your diagnosis, medication, and other characteristics, we’ll send you an email invitation to participate. All studies are voluntary and not required.
We hope you participate in ArthritisPower’s long-term study to understand how arthritis patients are doing over time. This involves downloading the ArthritisPower app and taking the ArthritisPower health assessment at least once every 6 months.
Contribute to Our Long-Term Study
You can also use the data to see how you’re doing over time and to even share the data with your doctor.

ArthritisPower was created by a 501(c)3 nonprofit Global Healthy Living Foundation, its patient community CreakyJoints, and researchers at the University of Alabama at Birmingham.

There are a few ways to contribute to research through ArthritisPower:

Recent ArthritisPower Research Studies

57% of Arthritis Patients Have Tried Marijuana or CBD for Medical Reasons

CreakyJoints, the patient organization behind ArthritisPower, wanted to understand how our arthritis patient community perceives and uses medical marijuana and CBD, so we conducted a survey to find out more. In research presented at the 2019 Annual European Congress of Rheumatology (EULAR) meeting in Madrid, Spain, we gave 1,059 patients with arthritis a 77-item survey to delve deeper into their usage of marijuana and CBD. Read about our findings.

The Quality of Life of People Living with Psoriatic Arthritis

Some 203 psoriatic arthritis (PsA) patients in the ArthritisPower research registry participated in this study. Overall, the study found that adults with psoriatic arthritis (PsA) experienced high unemployment and a significant impact on their personal relationships. Learn more about what we found.

82% of People with Gout Think It’s Best Managed with Diet Changes

When researchers, including those from ArthritisPower, surveyed 178 people with gout about their knowledge of the condition, more than 80 percent of respondents said they believed gout is best managed by diet changes, such as limiting consumption of certain foods like red meat, organ meats, and seafood. Read more.

Currently our research includes the following conditions: Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, osteoporosis/osteopenia/low bone mineral density, osteoarthritis (degenerative arthritis), fibromyalgia, gout, juvenile idiopathic arthritis, inflammatory bowel disease (e.g. Crohn’s disease, ulcerative colitis), lupus, scleroderma (systemic sclerosis), polymyositis, dermatomyositis, Axial spondyloarthritis (axSpA), non-radiographic axSpA, D.I.S.H. diffuse idiopathic skeletal hyperostosis (D.I.S.H.) and Sjögren’s syndrome.

Yes, study-related records identifying ArthritisPower participants will be kept confidential and, to the extent permitted by applicable laws and/or regulations, will not be made publicly available.